ELTX · Company research
Elicio Therapeutics, Inc. (ELTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Price, News & Analysis - Kalkine | Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Price, News & Analysis Kalkine | View source ↗ | Kalkine | Oct 9, 2026 | neutral | 0 | 0.6 |
| ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints - Stocktwits | ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics (ELTX) Slips 2.16% to $1.81, Drifting Toward Support at $1.72 - Wave Equality - https://www.siam.in/ | Elicio Therapeutics (ELTX) Slips 2.16% to $1.81, Drifting Toward Support at $1.72 - Wave Equality https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 9, 2026 | neutral | 0 | 0.6 |
| A pancreatic cancer study missed its main goal. Elicio presents new analyses Oct. 23. - Stock Titan | A pancreatic cancer study missed its main goal. Elicio presents new analyses Oct. 23. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Knoll Capital group discloses 5.3% Elicio Therapeutics stake (ELTX) - Stock Titan | Knoll Capital group discloses 5.3% Elicio Therapeutics stake (ELTX) Stock Titan | View source ↗ | Stock Titan | Jul 8, 2026 | neutral | 0 | 0.6 |
| Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - TradingView | Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment TradingView | View source ↗ | TradingView | Jul 2, 2026 | neutral | 0 | 0.6 |
| Why Is ELTX Stock Falling Today? - Stocktwits | Why Is ELTX Stock Falling Today? Stocktwits | View source ↗ | Stocktwits | Jul 2, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: QURE, FTHM, ELTX | Losers: ADTX, LILA, GDC - Trefis | Market Movers | Winners: QURE, FTHM, ELTX | Losers: ADTX, LILA, GDC Trefis | View source ↗ | Trefis | Jun 18, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics rebounds as investors refocus on subgroup data and a revised Phase 3 plan | ELTX Stock News - Quiver Quantitative | Elicio Therapeutics rebounds as investors refocus on subgroup data and a revised Phase 3 plan | ELTX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 17, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics (ELTX) Is Down 69.9% After Phase 2 ELI-002 Miss in Pancreatic Cancer Trial - Simply Wall Street | Elicio Therapeutics (ELTX) Is Down 69.9% After Phase 2 ELI-002 Miss in Pancreatic Cancer Trial Simply Wall Street | View source ↗ | Simply Wall Street | Jun 16, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX) - PR Newswire | Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX) PR Newswire | View source ↗ | PR Newswire | Jun 16, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics Shares Plunge After Pancreatic Cancer Study Misses Main Goal (ELTX) - Yahoo Finance | Elicio Therapeutics Shares Plunge After Pancreatic Cancer Study Misses Main Goal (ELTX) Yahoo Finance | View source ↗ | Yahoo Finance | Jun 15, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics stock tumbles after trial misses endpoint - Investing.com | Elicio Therapeutics stock tumbles after trial misses endpoint Investing.com | View source ↗ | Investing.com | Jun 15, 2026 | neutral | 0 | 0.6 |
| Elicio Therapeutics Pancreatic Cancer Study Disappoints - Benzinga | Elicio Therapeutics Pancreatic Cancer Study Disappoints Benzinga | View source ↗ | Benzinga | Jun 15, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.